<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587155</url>
  </required_header>
  <id_info>
    <org_study_id>ASNS-BRAIN001</org_study_id>
    <nct_id>NCT03587155</nct_id>
  </id_info>
  <brief_title>Study on the Mechanism of Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene Mutation</brief_title>
  <official_title>Study on the Mechanism of Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene Mutation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Natural Science Foundation of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to analyze a brain sample and/or peripheral blood by single cell
      RNA seq from aborted embryos with ASNS mutation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Congenital microcephaly could cause by gene mutation. Asparagine synthetase deficiency, which
      is caused by ASNS mutation, is a rare autosomal recessive neurometabolic disorder. It is
      characterized by severe developmental delay, congenital microcephaly, seizures. The
      investigators found a family with ASNS mutaion. The investigators propose to analyze a brain
      sample and/or peripheral blood by single cell RNA seq from aborted embryos with ASNS
      mutation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 28, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of ASNS gene mutation on RNA expression in prefrontal cortex cells of brain tissue</measure>
    <time_frame>2018.06-2020.12</time_frame>
    <description>Detect RNA expression in prefrontal cortex cells by single cell RNA sequencing.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Asparagine Synthetase Deficiency</condition>
  <condition>Genetic Diseases, Inborn</condition>
  <arm_group>
    <arm_group_label>Mutation</arm_group_label>
    <description>Embryo or infant with ASNS mutation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Embryo or infant without ASNS mutation.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Extract DNA from brain tissue or peripheral blood.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        abortive embryo or infant.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mutation Group: Having ASNS gene mutation by DNA exon sequencing.

          -  Control Group: No ASNS gene mutation by DNA exon sequencing.

        Exclusion Criteria:

          -  Mutation Group: N/A.

          -  Control Group: Having other gene mutation which also effect neurodevelopment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Chen, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bo Chen, M.D., Ph.D.</last_name>
    <phone>+86 15844023910</phone>
    <email>bchen223@jlu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xinyu Hong, M.D., Ph.D.</last_name>
    <email>3294051@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bo Chen</name>
      <address>
        <city>Chang Chun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bo Chen, M.D., Ph.D.</last_name>
      <phone>+8615844023910</phone>
      <email>bchen223@jlu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xinyu Hong, M.D., Ph.D.</last_name>
      <email>3294051@qq.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 3, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>July 3, 2018</last_update_submitted>
  <last_update_submitted_qc>July 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Bo Chen</investigator_full_name>
    <investigator_title>Associate Chief Physician</investigator_title>
  </responsible_party>
  <keyword>ASNS, single cell RNA seq, Neurodevelopmental Dysplasia,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

